Varian Medical Systems to Expand Operations in Atlanta | Varian

{ "pageType": "news-article", "title": "Varian Medical Systems to Expand Operations in Atlanta", "articleDate": "10 de March de 2015", "introText": "", "category": "Corporate and Financial Releases" }

Varian Medical Systems to Expand Operations in Atlanta

ATLANTA and PALO ALTO, Calif., March 10, 2015 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR), the world's leading manufacturer of medical devices and software for treating cancer as well as a premier supplier of X-ray imaging components, today announced that it will expand its operations in Fulton County, Georgia. Company officials anticipate that this expansion will enable it to better serve its East Coast customers and accommodate anticipated growth that will create up to 100 new high-paying technical jobs over the next five years.

"Varian has chosen to consolidate and expand in Georgia simply because we are the best state in the nation for business," said Georgia Governor Nathan Deal. "Our state's highly skilled workforce, combined with Varian's local customer base of world-class healthcare institutions utilizing its technology in cancer treatment, makes Georgia the ideal location to support this company's ongoing growth."

Varian has a long history in the Atlanta area, with an office in Marietta for over 30 years. In 2012, Varian supported establishment of a clinical linear accelerator laboratory at the George W. Woodruff School of Mechanical Engineering at Georgia Tech University, for medical physics students to get hands-on experience with state-of-the-art radiation therapy equipment. 

Varian's local operations recently expanded with the acquisition of Velocity Medical Solutions, an Atlanta-based developer of specialized software for cancer clinics that was incubated at Emory University. Velocity was supported, in its early stages, by the Georgia Research Alliance, a nonprofit organization aligned with Georgia's Department of Economic Development, working to expand research and commercialization capacity in Georgia's universities to launch new companies, create high-value jobs, and transform lives.

"We anticipate that there will be significant worldwide growth in demand for technology and software that clinicians can use to improve outcomes when treating cancer," said Kolleen Kennedy, president of Varian's Oncology Systems business. "Our acquisition of the Velocity group was part of a larger strategy to produce more tools and software that support our clinical customers. The new facility in Atlanta will enable us to foster greater collaboration across our teams and make sure that we have the space to accommodate future growth. We sincerely appreciate the support we have received for this project from Georgia state officials."

According to Kennedy, the new Atlanta center will operate as an East Coast hub for Varian. "It will include a state-of-the-art customer visit facility so that customers in the Eastern part of the U.S. and in Europe do not need to come all the way to California to meet with us, see our products, and talk with us about their future technology needs," she said.

"We are pleased that Varian Medical Systems has chosen to make this investment in metro Atlanta and create new jobs in the medical and healthcare industry. This expansion is a testament to the extensive R&D happening at our universities and our strength as a national leader in the health IT sector," said Brian P. McGowan, executive vice president and chief operating officer of the Metro Atlanta Chamber.

Varian anticipates that the new center, which is located at 3290 Northside Parkway, will be ready for occupancy in November of this year.

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, focuses energy on saving lives by equipping the world with advanced technology for fighting cancer and for X-ray imaging. The company is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is also a premier supplier of X-ray imaging components, including tubes, digital detectors, and image processing software and workstations for use in medical, scientific, and industrial settings, as well as for security and non-destructive testing. Varian Medical Systems employs approximately 6,800 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit or follow us on Twitter.

Forward-Looking Statements 
Except for historical information, this news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning industry and market outlook, including customer demand and acceptance of products or technology; growth drivers; the company's future orders, revenues or other financial performance; the ability of the company's technology and products to treat cancer; and any statements using the terms "will," "anticipate(s)," "can," and "will be ready," or similar statements are forward-looking statements that involve risks and uncertainties that could cause the company's actual results to differ materially from those anticipated. Such risks and uncertainties include demand for the company's products; the company's ability to develop, commercialize, and deploy new products; the impact of competitive products and pricing; the effect of global economic conditions; the company's ability to meet legal and regulatory requirements; changes in the legal or regulatory environment; and the other risks listed from time to time in the company's filings with the Securities and Exchange Commission, which by this reference are incorporated herein. The company assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events, or otherwise.

Meryl Ginsberg, 650.424.6444


To view the original version on PR Newswire, visit:

SOURCE Varian Medical Systems